Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 210929
Company: HANGZHOU ZHONGMEI

Products on ANDA 210929

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TACROLIMUS	TACROLIMUS	EQ 0.5MG BASE	CAPSULE;ORAL	Discontinued	None	No	No
TACROLIMUS	TACROLIMUS	EQ 1MG BASE	CAPSULE;ORAL	Discontinued	None	No	No
TACROLIMUS	TACROLIMUS	EQ 5MG BASE	CAPSULE;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 210929

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/17/2023	ORIG-1	Approval		STANDARD		Label is not available on this site.